Self-cross-linkable hydrogels composed of partially oxidized alginate and gelatin for myocardial infarction repair

Journal of Bioactive and Compatible Polymers

Volumn 28, Issue 2, 2013, Pages 126-140

  Bai, Xiuping ^a   Fang, Rui ^a   Zhang, Song ^b   Shi, Xinli ^c   Wang, Zeli ^a   Chen, Xiongbiao ^d   Yang, Jing ^e   Hou, Xiaolu ^f   Nie, Yongzhan ^b   Li, Yu ^a   Tian, Weiming ^a,b  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Food and Drug Administration   (China)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e HARBIN UNIVERSITY OF COMMERCE   (China)

^f HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Alginate; cardiac tissue engineering; cross linking; degradation; gelatin; hydrogel; myocardial infarction

Indexed keywords

ALGINATE HYDROGELS; CARDIAC REMODELING; CARDIAC TISSUE ENGINEERING; COVALENT CROSSLINKING; EXTRACELLULAR MATRICES; GELATIN; MYOCARDIAL INFARCTION; OXIDIZED ALGINATES;

ALGINATE; BIODEGRADATION; CELL ADHESION; CROSSLINKING; DEGRADATION; ECHOCARDIOGRAPHY; MECHANICAL PROPERTIES; OXIDATION; REPAIR; TISSUE ENGINEERING;

HYDROGELS;

ALGINIC ACID; GELATIN; GELATINASE A; GELATINASE B; SODIUM CHLORIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CELL ADHESION; CELL INFILTRATION; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; ECHOCARDIOGRAPHY; HEART INFARCTION; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MECHANICAL PROBE; NONHUMAN; RAT; ZYMOGRAPHY;

RATTUS;

EID: 84875837637     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911512473230     Document Type: Article

References (52)

1. Kelly D, Khan S, Cockerill G, et al. Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur J Heart Fail. 2008 ; 10 (2). 133-139
2. Mann DL. Mechanisms and models in heart failure - a combinatorial approach. Circulation. 1999 ; 100 (9). 999-1008 (Pubitemid 29407182)
3. Lee RT, Davis ME, Motion JPM, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation. 2005 ; 111 (4). 442-450 (Pubitemid 40204428)
4. Jiang XJ, Wang T, Li XY, et al. Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction. J Biomed Mater Res A. 2009 ; 90 (2). 472-477
5. Lee RJ, Christman KL. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol. 2006 ; 48 (5). 907-913 (Pubitemid 44292446)
6. Lee RT, Davis ME, Hsieh PCH, et al. Custom design of the cardiac microenvironment with biomaterials. Circ Res. 2005 ; 97 (1). 8-15 (Pubitemid 40982317)
7. Murry CE, Garbern JC, Minami E, et al. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials. 2011 ; 32 (9). 2407-2416
8. Kikuchi A, Okano T. Pulsatile drug release control using hydrogels. Adv Drug Deliv Rev. 2002 ; 54 (1). 53-77 (Pubitemid 34075314)
9. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials. 1999 ; 20 (1). 45-53 (Pubitemid 29002544)
10. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003 ; 24 (24). 4337-4351 (Pubitemid 36960132)
11. Landa N, Miller L, Feinberg MS, et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008 ; 117 (11). 1388-1396 (Pubitemid 351506386)
12. Tsur-Gang O, Ruvinov E, Landa N, et al. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials. 2009 ; 30 (2). 189-195
13. Hao XJ, Silva EA, Mansson-Broberg A, et al. Angiogenic effects of sequential release of VEGF-A(165) and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res. 2007 ; 75 (1). 178-185 (Pubitemid 46876668)
14. Cohen S, Ruvinov E, Leor J. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials. 2011 ; 32 (2). 565-578
15. Leor J, Tuvia S, Guetta V, et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol. 2009 ; 54 (11). 1014-1023
16. Balakrishnan B, Jayakrishnan A. Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds. Biomaterials. 2005 ; 26 (18). 3941-3951 (Pubitemid 40038785)
17. Boontheekul T, Kong HJ, Mooney DJ. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials. 2005 ; 26 (15). 2455-2465 (Pubitemid 39600698)
18. Bouhadir KH, Lee KY, Alsberg E, et al. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog. 2001 ; 17 (5). 945-950 (Pubitemid 32972660)
19. Gao CM, Liu MZ, Chen J, et al. Preparation and controlled degradation of oxidized sodium alginate hydrogel. Polym Degrad Stab. 2009 ; 94 (9). 1405-1410
20. Alsberg E, Anderson KW, Albeiruti A, et al. Engineering growing tissues. Proc Natl Acad Sci U S A. 2002 ; 99 (19). 12025-12030
21. Luna SM, Gomes ME, Mano JF, et al. Development of a novel cell encapsulation system based on natural origin polymers for tissue engineering applications. J Bioact Compat Polym. 2010 ; 25 (4). 341-359
22. Yao R, Zhang R, Yan Y, Wang X. In vitro angiogenesis of 3D tissue engineered adipose tissue. J Bioact Compat Polym. 2009 ; 24 (1). 5-24
23. Balakrishnan B, Mohanty M, Umashankar PR, et al. Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials. 2005 ; 26 (32). 6335-6342 (Pubitemid 40828389)
24. Mohamadnia Z, Zohuriaan-Mehr MJ, Kabiri K, et al. pH-Sensitive IPN hydrogel beads of carrageenan-alginate for controlled drug delivery. J Bioact Compat Polym. 2007 ; 22 (3). 342-356 (Pubitemid 46934061)
25. Dreesmann L, Ahlers M, Schlosshauer B. The pro-angiogenic characteristics of a cross-linked gelatin matrix. Biomaterials. 2007 ; 28 (36). 5536-5543 (Pubitemid 47599645)
26. Kuo CK, Ma PX. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials. 2001 ; 22 (6). 511-521 (Pubitemid 32015873)
27. Polyak B, Geresh S, Marks RS. Synthesis and characterization of a biotin-alginate conjugate and its application in a biosensor construction. Biomacromolecules. 2004 ; 5 (2). 389-396 (Pubitemid 38404474)
28. Doursout MF, Wouters P, Kashimoto S, et al. Measurement of cardiac function in conscious rats. Ultrasound Med Biol. 2001 ; 27 (2). 195-202 (Pubitemid 32303473)
29. Litwin SE, Katz SE, Morgan JP, et al. Serial echocardiographic assessment of left-ventricular geometry and function after large myocardial-infarction in the rat. Circulation. 1994 ; 89 (1). 345-354 (Pubitemid 24026509)
30. Kloner RA, Dow J, Chung G, et al. Intramyocardial injection of DNA encoding vascular endothelial growth factor in a myocardial infarction model. J Thromb Thrombolysis. 2000 ; 10 (3). 285-289 (Pubitemid 32041138)
31. Giricz Z, Lalu MM, Csonka C, et al. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J Pharmacol Exp Ther. 2006 ; 316 (1). 154-161 (Pubitemid 41832592)
32. Vervoort L, Vinckier I, Moldenaers P, et al. Inulin hydrogels as carriers for colonic drug targeting. Rheological characterization of the hydrogel formation and the hydrogel network. J Pharm Sci. 1999 ; 88 (2). 209-214 (Pubitemid 29084733)
33. Al-Shamkhani A, Duncan R. Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in-vivo. J Bioact Compat Polym. 1995 ; 10 (1). 4-13
34. Vanhoutte D, Schellings M, Pinto Y, et al. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res. 2006 ; 69 (3). 604-613 (Pubitemid 43139724)
35. Wagner WR, Nelson DM, Ma ZW, et al. Intra-myocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges. Acta Biomater. 2011 ; 7 (1). 1-15
36. Mo XM, Iwata H, Matsuda S, et al. Soft tissue adhesive composed of modified gelatin and polysaccharides. J Biomater Sci Polym Ed. 2000 ; 11 (4). 341-351 (Pubitemid 30406785)
37. Yang JS, Xie YJ, He W. Research progress on chemical modification of alginate: a review. Carbohydr Polym. 2011 ; 84 (1). 33-39
38. Ifkovits JL, Tous E, Minakawa M, et al. Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci U S A. 2010 ; 107 (25). 11507-11512
39. Erogǧlu Muzaffer, Öztürk Eylem, Özdemv́r Nalan, et al. Mitomycin-C-loaded alginate carriers for bladder cancer chemotherapy: in vivo studies. J Bioact Compat Polym. 2005 ; 20 (2). 197-208
40. Bouhadir KH, Kruger GM, Lee KY, et al. Sustained and controlled release of daunomycin from cross-linked poly(aldehyde guluronate) hydrogels. J Pharm Sci. 2000 ; 89 (7). 910-919
41. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix - when is enough?. Circulation. 2003 ; 108 (11). 1395-1403 (Pubitemid 37174420)
42. Mukherjee R, Mingoia JT, Bruce JA, et al. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006 ; 291 (5). H2216 - H2228
43. Matsumura S, Iwanaga S, Mochizuki S, et al. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest. 2005 ; 115 (3). 599-609 (Pubitemid 40322234)
44. Lee RT, Ducharme A, Frantz S, et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000 ; 106 (1). 55-62 (Pubitemid 30437240)
45. Bowen FW, Jones SC, Narula N, et al. Restraining acute infarct expansion decreases collagenase activity in borderzone myocardium. Ann Thorac Surg. 2001 ; 72 (6). 1950-1956 (Pubitemid 34001448)
46. Mukherjee R, Zavadzkas JA, Saunders SM, et al. Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann Thorac Surg. 2008 ; 86 (4). 1268-1276
47. Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol Biosci. 2006 ; 6 (8). 623-633 (Pubitemid 44329266)
48. Davis KA, Burdick JA, Anseth KS. Photoinitiated crosslinked degradable copolymer networks for tissue engineering applications. Biomaterials. 2003 ; 24 (14). 2485-2495 (Pubitemid 36407665)
49. Kong HJ, Alsberg E, Kaigler D, et al. Controlling degradation of hydrogels via the size of cross-linked junctions. Adv Mater. 2004 ; 16 (21). 1917-1921
50. Van Amerongen MJ, Harmsen MC, Petersen AH, et al. The enzymatic degradation of scaffolds and their replacement by vascularized extracellular matrix in the murine myocardium. Biomaterials. 2006 ; 27 (10). 2247-2257 (Pubitemid 41774536)
51. Chou AI, Akintoye SO, Nicoll SB. Photo-crosslinked alginate hydrogels support enhanced matrix accumulation by nucleus pulposus cells in vivo. Osteoarthritis Cartilage. 2009 ; 17 (10). 1377-1384
52. Leor J, Rozen L, Zuloff-Shani A, et al. Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation. 2006 ; 114: I94 - I100